Cervical Cancer
UK study supports extending HPV testing interval
Recent findings suggest that with HPV tests, intervals between cervical screenings can be extended to 5 years after a negative result in women aged 25 to 49 years and even longer for women aged older than 50 years.
Sexual minority individuals less likely to undergo cervical cancer screening
Individuals who identified as a sexual minority had lower odds of ever undergoing Pap testing compared with heterosexual individuals, according to a study published in Cancer.
Decrease in cervical cancer rates may be linked to HPV screening, vaccination
A decrease in cervical cancer rates in the United States, most notably among younger women, may be associated with HPV vaccination approval, according to a retrospective, cross-sectional study published in JAMA Network Open.
Higher county densities of PCPs associated with earlier cancer stage at diagnosis
SAN DIEGO — A higher density of primary care physicians was associated with an earlier stage of cervical cancer at diagnosis, according to findings presented at the ACOG Annual Clinical & Scientific Meeting.
HPV detection via menstrual pad ‘shows promise’ in study
SAN DIEGO — Passively self-collected menstrual blood for the detection of HPV showed results that were highly concordant with clinician-collected sampling and had greater acceptance among patients, researchers reported here.
VIDEO: Stephanie Faubion, MD, reports on latest updates in women’s health
CHICAGO — In this video interview with Healio, Stephanie Faubion, MD, MBA, FACP, NCMP, IF, highlights recent research on women’s health, which she discussed during her presentation here.
Roundtables aim to improve outcomes for, reduce disparities in breast, cervical cancers
Arif Kamal, MD, MBA, MHS, chief patient officer at American Cancer Society, spoke with Healio about two national roundtables the society will launch to drive progress against breast cancer and cervical cancer.
Minimally invasive hysterectomy yields worse outcomes than open surgery in cervical cancer
Minimally invasive surgery conferred lower survival rates than open surgery among women with cervical cancer, according to randomized phase 3 trial results presented at Society of Gynecologic Oncology 2022 Annual Meeting on Women's Cancer.
Atezolizumab safe before, during chemoradiation, active in women with cervical cancer
Atezolizumab administered before and during chemoradiation appeared safe and demonstrated immune-modulating activity among women with node-positive locally advanced cervical cancer, according to study results.
Cancer programs aim to address critical gaps in screening due to pandemic
Cancer screening remains in need of urgent attention, and online resources may help facilities close gaps and address screenings missed in 2020, according to a prospective quality improvement study published in Cancer.